2021 annual financial data
Sinovac Biotech 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was 79.24%.
Operating income was 17,553,257,000 USD and net income was 8,467,480,000 USD.
Operating cash flow was 15,352,541,000 USD.
Get free Sinovac Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 19,374,904,000 USD
- Operating income
- 17,553,257,000 USD
- Net income
- 8,467,480,000 USD
- Operating cash flow
- 15,352,541,000 USD